Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 03, 2026
Why Is Arm Holdings (ARM) Stock Down -6.75% Today?

Why Is Arm Holdings (ARM) Stock Down -6.75% Today?

Key Takeaways

  • Arm Holdings (ARM) shares tumbled approximately 6.75% in Monday's trading session, sliding from a prior close of $239.69 to around $223.50.
  • The decline extends a post-earnings selloff that began after the company's fiscal Q1 2027 report, released on July 29, failed to impress a market demanding exceptional performance from its premium-valued AI stocks.
  • Investors zeroed in on the company's downward revision to full-year royalty revenue growth guidance — trimmed to approximately 18% from 20% — driven by smartphone market softness and rising memory costs pressuring device sales.
  • AGI CPU revenue guidance was held steady at over $1 billion for the second consecutive quarter, with management citing TSMC foundry capacity constraints as the limiting factor despite demand exceeding $2 billion.
  • Multiple Wall Street firms, including Rosenblatt, Wells Fargo, and BofA Securities, have cut their price targets on ARM since the earnings release, citing margin compression and valuation concerns.
  • Traders are now watching for any updates on AGI CPU supply chain progress and the company's fiscal Q2 performance, with the next meaningful catalyst likely being the FY27 Q3 guidance update.

Opening Summary

Arm Holdings plc (ARM), the Cambridge-based semiconductor intellectual property giant whose chip architectures power 99% of the world's smartphones, saw its shares fall sharply on Monday, declining roughly 6.75% to trade near $223.50, down from Friday's closing price of $239.69. The drop deepens a selloff that has now erased nearly 30% of the stock's value over the past month and places shares more than 50% below their June 2026 all-time high of $452.70. The move comes as markets continue to digest the company's fiscal first-quarter 2027 earnings report, which delivered solid headline numbers but exposed cracks in the narrative that had propelled ARM to sky-high valuations earlier this year.

Earnings That Beat Estimates — But Not Expectations

Arm reported fiscal Q1 2027 results on July 29 after the market close, posting revenue of $1.29 billion, up 22% year-over-year and modestly ahead of the $1.26 billion consensus estimate. Adjusted earnings per share came in at $0.45, handily beating the $0.40 analysts had projected. Licensing revenue grew 23% to $574 million, while royalty revenue climbed 22% to $715 million, fueled by another quarter of triple-digit growth in data center royalties as hyperscale cloud providers continued ramping Arm-based server chip deployments.

So why are shares falling? For a stock trading at well over 100 times forward earnings, "in-line" simply is not enough. The market had priced ARM for flawless execution and accelerating momentum. Instead, investors received a report that was merely solid — and an outlook that contained subtle but meaningful disappointments. The GAAP operating margin contracted to roughly 7%, with research and development expenses surging 29% year-over-year to $840 million, or 65% of revenue, as the company invests heavily in next-generation architectures and its AGI CPU product line.

Royalty Guidance Cut Spoils the Narrative

The most consequential element of Arm's quarterly update was its downward revision to full-year royalty revenue growth. Management now expects royalty revenue to expand at approximately 18% in fiscal 2027, down from a prior forecast of around 20%. The culprit: softening smartphone demand, exacerbated by elevated memory prices that are driving up device costs and dampening consumer appetite.

While Arm's data center royalty stream continues to double year-over-year — with Neoverse core shipments surpassing 1.5 billion units and adoption accelerating across NVDA, AMZN, GOOGL, and MSFT — the smartphone segment still represents a sizable portion of overall royalties. The royalty guidance cut, though modest in percentage-point terms, punctured the assumption that Arm's AI-driven data center growth could entirely insulate it from cyclical mobile headwinds.

AGI CPU: Demand Is There, but Supply Is Not

Arm's high-stakes venture into manufacturing its own server CPUs — the Arm AGI CPU, announced in March 2026 — remains the most closely watched component of the growth story. On the earnings call, CEO Rene Haas confirmed that demand for the chip has surpassed $2 billion across fiscal 2027 and 2028, with first units already delivered to multiple customers including Oracle. Yet for the second consecutive quarter, the company declined to raise its AGI CPU revenue guidance beyond the $1 billion threshold, citing limited wafer supply from TSMC as the binding constraint.

This is becoming a frustration point for investors. The $2 billion demand figure signals enormous market appetite, but the inability to convert that demand into near-term revenue — combined with the acknowledgment that initial AGI CPU gross margins will be just 35% to 45%, a sharp contrast to Arm's 97% core IP margins — has tempered enthusiasm. Until Arm can demonstrate that its CPU business can scale meaningfully and profitably, the stock's premium multiple will remain under scrutiny.

Analyst Community Turns More Cautious

In the days following the earnings release, several prominent Wall Street firms trimmed their price targets on ARM. Rosenblatt lowered its target to $250 from $270 while maintaining a Buy rating, citing reduced gross margin assumptions and higher expense forecasts. Wells Fargo cut its target to $280 from $350, pointing to multiple compression across the semiconductor industry. BofA Securities delivered the most dramatic reduction, slashing its target to $260 from $460, explicitly citing valuation concerns. The consensus message from analysts: the long-term thesis around Arm's AI and data center opportunity remains intact, but the near-term path is bumpier than previously assumed.

Market Context and Trading Activity

Monday's decline in ARM shares occurred against a mixed market backdrop. Broader U.S. equity futures pointed higher, supported by de-escalation in U.S.-Iran tensions after President Trump called off planned military strikes and announced renewed diplomatic talks. Amazon's blowout earnings on Friday lifted AI sentiment broadly, but Arm appears to be trading on its own company-specific dynamics rather than benefiting from the sector tailwind.

The semiconductor sector remains under considerable pressure more broadly. The Philadelphia Semiconductor Index tumbled 20.6% in July — its worst monthly performance since 2008 — and even Friday's modest 0.07% rebound left the index more than 20% below its June record high. Arm's elevated beta of approximately 3.77 means it amplifies these sector moves, and with valuation multiples still priced for perfection, any hint of deceleration is met with outsized selling pressure.

Trading volume in ARM has been elevated throughout the post-earnings period, indicating active institutional repositioning. The stock has now broken below several key technical levels, including its 50-day and 200-day moving averages, which may exacerbate selling pressure from systematic and momentum-driven strategies.

What Comes Next for ARM

Looking ahead, several developments will be critical for ARM's trajectory. The company's fiscal Q2 2027 results, expected in approximately three months, will provide the next official read on royalty trends and AGI CPU progress. Of particular importance will be whether smartphone royalty headwinds stabilize or worsen, and whether the company can demonstrate any improvement in its TSMC wafer allocation.

The broader AI investment cycle also looms large. Recent signals from major cloud providers have been mixed — Microsoft and Amazon delivered strong capex outlooks, but any broader pullback in hyperscaler spending would directly impact the addressable market for Arm's data center products. Additionally, Arm's decision to stop disclosing Remaining Performance Obligations (RPO) and Arm Total Access license counts has removed visibility into forward indicators that investors had relied upon.

Risks remain tilted to both sides. On the upside, any acceleration in AGI CPU supply availability or upward revision to the $1 billion revenue target would likely be received enthusiastically. On the downside, further deterioration in smartphone end-markets, additional analyst downgrades, or signs that AI infrastructure spending is plateauing could extend the stock's drawdown. For now, Arm's premium valuation means it must continue to deliver exceptional — not merely solid — results.

Trending AI Robots

For traders seeking data-driven approaches to navigate volatility in stocks like ARM, Tickeron offers a curated selection of AI-powered trading bots on its Trending AI Robots page. The platform features hundreds of algorithmic trading bots covering thousands of tickers across diverse strategies, timeframes, and performance profiles — but only those demonstrating the strongest real-time performance under current market conditions are highlighted in the Trending section. These bots vary by trading style, holding period, and risk parameters, allowing users to explore automated approaches tailored to different market environments. Visit the Trending AI Robots page to explore which strategies are currently leading the pack.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ARM

ARM's RSI Oscillator climbs out of oversold territory

The RSI Indicator for ARM moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 18 similar instances when the indicator left oversold territory. In of the 18 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARM advanced for three days, in of 193 cases, the price rose further within the following month. The odds of a continued upward trend are .

ARM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARM as a result. In of 46 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ARM moved below its 50-day moving average on July 13, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ARM crossed bearishly below the 50-day moving average on July 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ARM entered a downward trend on July 31, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (29.674) is normal, around the industry mean (15.194). P/E Ratio (244.582) is within average values for comparable stocks, (218.742). Projected Growth (PEG Ratio) (1.968) is also within normal values, averaging (1.896). ARM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (49.751) is also within normal values, averaging (41.978).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Analog Devices (NASDAQ:ADI), Marvell Technology (NASDAQ:MRVL), QUALCOMM (NASDAQ:QCOM).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 176.81B. The market cap for tickers in the group ranges from 13.43K to 4.86T. NVDA holds the highest valuation in this group at 4.86T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was -3%. For the same Industry, the average monthly price growth was -18%, and the average quarterly price growth was 36%. PI experienced the highest price growth at 19%, while NXPI experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was -14% and the average quarterly volume growth was -45%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 51
Price Growth Rating: 52
SMR Rating: 75
Profit Risk Rating: 74
Seasonality Score: -22 (-100 ... +100)
View a ticker or compare two or three
ARM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Semiconductors

Profile
Details
Industry
N/A
Address
110 Fulbourn Road
Phone
+44 1223400400
Employees
8330
Web
https://www.arm.com
Interact to see
Advertisement
Chevron’s upcoming Q4 report highlights its first full quarters integrating Hess, following record Q3 production of 4.1 million barrels of oil equivalent per day (MMboe/d). Comparing CVX with ExxonMobil and Shell provides insight into how each supermajor is navigating a volatile oil market with prices hovering below $60 per barrel.
SoFi Technologies is set to report Q4 and full-year 2025 earnings on January 30, 2026, closing out a pivotal year for the digital finance platform. With its fiscal year ending December 31, the report follows a strong Q3 that featured record net revenue of $962 million and member growth to 12.6 million, a 35% year-over-year increase.
ASML reported Q4 2025 net sales of $9.7 billion, gross margin of 52.2%, net income of $2.8 billion, and record net bookings of $13.2 billion, including $7.4 billion in EUV orders.
IDEXX Laboratories (IDXX) reports Q4 2025 earnings on February 2, 2026, with analysts expecting continued strength in recurring revenue from companion animal diagnostics. Danaher (DHR) reports on January 28, while Thermo Fisher Scientific (TMO) follows in early February, with both facing low-single-digit core growth expectations across life sciences and diagnostics.
NIO Inc. (NIO) produced its one-millionth vehicle this week at its Hefei facility, closing out a record 2025 delivery total of 326,028 units, up 46.9% year over year. The milestone, announced January 6, reflects accelerating demand for core models such as the ES8 SUV and newer brands ONVO and Firefly.
Faraday Future Intelligent Electric Inc. (FFAI) shares traded near $1.02 this week following announcements of a non-binding $10 million stock purchase term sheet with AIxCrypto (AIxC) and preparations for a Stockholders’ Day on January 7, 2026. Trading volume spiked amid broader EV volatility, highlighting investor attention on FFAI’s pivot toward AI-enhanced mobility and robotics.
BTQ Technologies Corp. (BTQ), formerly BTQQF, launched the Bitcoin Quantum testnet this week—the first quantum-safe Bitcoin fork, 17 years after Bitcoin’s genesis block. The move coincided with inclusion in the $524.5 million VanEck Quantum Computing UCITS ETF, boosting European investor visibility.
VEU targets large- and mid-cap ex-U.S. stocks with ~3,800 holdings. VXUS offers broad all-cap exposure, including ~8,600 stocks across small-, mid-, and large-cap companies.
Apple (AAPL) reports Q1 FY2026 earnings on January 29, with consensus revenue at $138.5B and EPS at $2.67, supported by strong demand for iPhone 17 models, higher average selling prices, and continued Services growth. Microsoft (MSFT) reports Q2 FY2026 on January 28, expecting $80.3B revenue and $3.91 EPS, driven by Azure AI adoption and enterprise cloud expansion, though elevated capex spending (~$35B/quarter) remains under scrutiny.
Visa Inc. (V), the global payments network leader, reports Q1 FY2026 earnings on January 29, 2026, for the period ending December 31, 2025. This marks the start of FY2026 following a strong FY2025, where net revenue reached $40 billion (+11%) and EPS climbed to $11.47 (+14%). Investors are watching closely for insights into consumer spending, cross-border travel recovery, and digital payment adoption.
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.